Drug intelligence / Profile preview

oleanolic acid

Development stage
Preclinical
Lead developer
Biostar Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Oleanolic acid is a naturally occurring pentacyclic triterpenoid compound found in many plants, including olives, apples, and various medicinal herbs. It is widely distributed in food and medicinal plants as an aglycone of saponins. Pharmacologically, oleanolic acid exhibits a broad spectrum of biological activities including hepatoprotective, antitumor, antibacterial, antiviral (including weak anti-HIV and anti-HCV activity), antiparasitic, antioxidant, and anti-inflammatory effects. Its mechanisms include induction of phase 2 detoxifying enzymes such as NADH–quinone oxidoreductase and heme oxygenase 1 via activation of the Nrf2 pathway; inhibition of inflammatory mediators like inducible nitric oxide synthase (iNOS) and cyclooxygenase 2; modulation of immune responses; and cytoprotective effects against oxidative stress. While relatively non-toxic at dietary levels or traditional use doses, high doses may cause liver enzyme elevation indicating potential hepatotoxicity[1][4][5][9].

Other names
oleanic acidCaryophyllinAstrantiagenin C(3.beta.)-3-Hydroxyolean-12-en-28-oic acidOleanolOleanoic Acid HydrateOleanolsA currencyureOleanolic acid (Standard)Oleanolic acid, United States Pharmacopeia (USP) Reference Standard
02

Targets

NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)

Beyond the preview

Go deeper on oleanolic acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on oleanolic acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call